Cardiac Arrhythmias in Greenland

Brief summary (registry, in English)

The study is a phd-study comprising several substudies focusing on cardiac arrhythmias, mainly atrial fibrillation, among Greenlanders in Greenland. Some previous studies have indicated that the prevalence may be lower than among Westerners, however; studies have also indicated that atrial fibrillation is underdiagnosed. These studies aim to: * Estimate the prevalence of AF among Greenlanders in Greenland aged 55 years or older. * Estimate the prevalence of well-known risk factors among those found to have AF * Explore the symptoms of those affected by AF in Greenland * Among part of the participants: estimate the prevalence of autonomic neuropathy as this may cause arrhythmias.

What you commit to

• Study type: Observational
• Participants enrolled: 200
• From 16 Apr 2022 to the primary completion date, 28 Mar 2023
• 1 site in 1 country
• Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Who the study is looking for

Age in the registry: 50 years to - · Sex: All

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.